康哲藥業(00867.HK)公布，獲澳門政府藥物監督管理局(ISAF)批准磷酸蘆可替尼乳膏新藥上市申請。產品用於治療12歲及以上青少年和成人患者伴面部受累的非節段型白癜風。
康哲藥業(00867.HK)磷酸蘆可替尼乳膏澳門新藥上市申請獲批
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.